SENSEX NIFTY
May 13, 2013, 10.31 PM IST | Source: Reuters

Ranbaxy to pay USD 500 million in US lawsuit settlement

Drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay USD 500 million in civil and criminal fines under the settlement agreement with the US Department of Justice.

Ranbaxy to pay USD 500 million in US lawsuit settlement

Drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay USD 500 million in civil and criminal fines under the settlement agreement with the US Department of Justice

The settlement has been in the works for some time. In December 2011, Ranbaxy set aside USD 500 million to resolve the potential criminal and civil liabilities related to the investigation by the government into its manufacturing practices and falsifying data.

The company reached a related settlement agreement with the US Food & Drug Administration in 2011.

 

Ranbaxy Labs stock price

On December 19, 2014, Ranbaxy Laboratories closed at Rs 617.45, down Rs 3.1, or 0.5 percent. The 52-week high of the share was Rs 697.50 and the 52-week low was Rs 306.05.


The company's trailing 12-month (TTM) EPS was at Rs 20.91 per share as per the quarter ended September 2014. The stock's price-to-earnings (P/E) ratio was 29.53. The latest book value of the company is Rs 25.82 per share. At current value, the price-to-book value of the company is 23.91.

Set email alert for

ADS BY GOOGLE

video of the day

Rupee weakness modest, see yields at 7.60% in Q1: Deutsche

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.